The therapy Earth cleared is one file short of transparent

EARTHSIDE REGULATORY COMMONS — The clearance runs long. The gap in it runs nine pages, and the whole argument is in that difference.

Those nine pages are a sealed medical file from Meridian: a retired desalination engineer, one of 140 patients in the colony's first cohort, who spiked an unexplained fever partway through treatment. Meridian's board logged the episode, called it unresolved, then sealed the file and told Earth's inspectors to stay out. Earth cleared the protocol anyway, provisionally, and wrote the seal into the terms. The clearance holds exactly as long as that file stays shut.

Sit with that for a second, because it's new. Earth has signed off on a therapy now reaching roughly twelve thousand patients across several cohorts, on the condition that it never look at the one case where the therapy appears to have gone wrong. The press note called this a milestone in off-world cooperation. The chart tells a different story. In medicine we have a word for a study that publishes its wins and locks its anomalies in a drawer. 'Milestone' isn't it.

To be fair to Meridian, the disclosure elsewhere is real. Dosing schedules, observation windows, harm definitions, all on the table for the 140- and 208-patient cohorts, feeding a disclosed database of some twelve thousand records. What isn't on the table anywhere is a human inspector walking into a clinic. The board approved this without a single physical inspection of the facilities doing the treating. First time that's happened for an off-world therapy at this scale.

"You cannot audit a fever from a summary of the fever," one public-health reviewer on the board's minority side told me, asking not to be named because the deliberations are still closed. "We were shown the shape of the hole and asked to certify the wall around it."

Meridian calls the seal sovereignty, not evasion (sovereignty is what evasion calls itself when it has a charter). The argument has a spine to it: a colony governs its own clinics, Earth's writ stops at the transfer gap, and by that logic the fever case is Meridian's business whether it gets resolved or not. Earthside regulators who signed off privately admit the point lands. They also note the alternative wasn't a cleaner protocol. It was no protocol, which would not have stopped the therapy, only the paperwork around it.

It won't stop the passengers either. A fourth cohort, 139 paying patients, departs for Meridian in sixty-one days under this same provisional framework, buying treatment on data that excludes the one record that actually speaks to whether the treatment is safe. Call it a clinical trial of its own: nobody's controlling for anything, nobody's blind, and the sample selects itself for people who ran out of better options.

What worries the reviewers isn't this case. It's the next one. A provisional clearance built around a sealed gap is a template, and nobody writes a template to use it once. Earth's board has now established, on the record, that an off-world polity can disclose what makes it look good, seal what doesn't, refuse the one inspection that would tell the difference, and still walk away with Earth's signature at the bottom of the page.

"Whatever we called this," the reviewer said, "we will be asked to call the next one the same thing."